PULMONX CORPORATION Increase (Decrease) in Accrued Liabilities
PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Accrued Liabilities of -$379.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-04
- PULMONX CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $786.00K, a 68.90% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$1.17M.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$443.00K, a 111.14% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $528.00K, a 27.87% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for fiscal 2025 was -$2.28M, a 593.29% decline from fiscal 2024.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for fiscal 2024 was $462.00K, a 85.45% decline from fiscal 2023.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for fiscal 2023 was $3.18M, a 2031.54% increase from fiscal 2022.
- PULMONX CORPORATION increase (decrease) in accrued liabilities for fiscal 2022 was $149.00K, a 96.90% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $786.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$379.00K 10-Q · filed 2026-08-04 | -$822.00K derived: sum of 3 quarters · filed 2026-08-04 | -$294.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$1.17M 10-Q · filed 2026-05-04 | -$1.61M derived: sum of 2 quarters · filed 2026-05-04 | -$1.08M derived: sum of 3 quarters · filed 2026-05-04 | $1.45M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $85.00K derived: sum of 2 quarters · filed 2026-03-10 | $2.61M derived: sum of 3 quarters · filed 2026-08-04 | -$2.28M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.06M derived: sum of 2 quarters · filed 2026-08-04 | -$1.84M 10-Q · filed 2025-11-12 | $2.14M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.36M 10-Q · filed 2026-08-04 | $1.61M derived: sum of 3 quarters · filed 2026-08-04 | $2.34M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | -$4.89M 10-Q · filed 2026-05-04 | -$915.00K derived: sum of 2 quarters · filed 2026-05-04 | -$183.00K derived: sum of 3 quarters · filed 2026-05-04 | $1.55M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.71M derived: sum of 2 quarters · filed 2026-03-10 | $6.44M derived: sum of 3 quarters · filed 2026-03-10 | $462.00K 10-K · filed 2026-03-10 | ||
| 2024-09-30 | $732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.47M derived: sum of 2 quarters · filed 2025-11-12 | -$3.51M 10-Q · filed 2025-11-12 | -$1.26M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$4.25M 10-Q · filed 2025-08-01 | -$1.99M derived: sum of 3 quarters · filed 2025-08-01 | -$1.57M derived: sum of 4 quarters · filed 2025-08-01 | ||
| 2024-03-31 | -$5.98M 10-Q · filed 2025-05-02 | -$3.73M derived: sum of 2 quarters · filed 2025-05-02 | -$3.31M derived: sum of 3 quarters · filed 2025-05-02 | -$327.00K derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.67M derived: sum of 2 quarters · filed 2025-02-25 | $5.65M derived: sum of 3 quarters · filed 2025-02-25 | $3.18M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $3.40M derived: sum of 2 quarters · filed 2024-11-01 | $923.00K 10-Q · filed 2024-11-01 | $3.31M derived: sum of 4 quarters · filed 2024-11-01 | ||
| 2023-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $501.00K 10-Q · filed 2024-08-02 | $2.89M derived: sum of 3 quarters · filed 2024-08-02 | $1.95M derived: sum of 4 quarters · filed 2024-08-02 | ||
| 2023-03-31 | -$2.48M 10-Q · filed 2024-05-03 | -$93.00K derived: sum of 2 quarters · filed 2024-05-03 | -$1.03M derived: sum of 3 quarters · filed 2024-05-03 | -$16.00K derived: sum of 4 quarters · filed 2024-05-03 | ||
| 2022-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.45M derived: sum of 2 quarters · filed 2024-02-27 | $2.46M derived: sum of 3 quarters · filed 2024-02-27 | $149.00K 10-K · filed 2024-02-27 | ||
| 2022-09-30 | -$940.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $77.00K derived: sum of 2 quarters · filed 2023-11-03 | -$2.24M 10-Q · filed 2023-11-03 | -$727.00K derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.30M 10-Q · filed 2023-08-04 | $213.00K derived: sum of 3 quarters · filed 2023-08-04 | $578.00K derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | -$2.31M 10-Q · filed 2023-05-08 | -$804.00K derived: sum of 2 quarters · filed 2023-05-08 | -$439.00K derived: sum of 3 quarters · filed 2023-05-08 | $745.00K derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.87M derived: sum of 2 quarters · filed 2023-03-01 | $3.06M derived: sum of 3 quarters · filed 2023-03-01 | $4.80M 10-K · filed 2023-03-01 | ||
| 2021-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.55M derived: sum of 2 quarters · filed 2022-11-08 | $3.29M 10-Q · filed 2022-11-08 | $4.00M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.93M 10-Q · filed 2022-08-08 | $1.87M 10-Q · filed 2021-08-10 | $3.63M derived: sum of 3 quarters · filed 2022-08-08 | $5.64M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $1.74M 10-Q · filed 2022-05-09 | $1.27M 10-Q · filed 2021-05-12 | $2.45M derived: sum of 2 quarters · filed 2022-05-09 | $4.46M derived: sum of 3 quarters · filed 2022-05-09 | $4.81M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.72M derived: sum of 2 quarters · filed 2022-03-01 | $3.07M derived: sum of 3 quarters · filed 2022-03-01 | $1.02M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.36M derived: sum of 2 quarters · filed 2021-11-09 | $310.00K 10-Q · filed 2021-11-09 | $1.63M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $351.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$1.70M 10-Q · filed 2021-08-10 | -$379.00K derived: sum of 3 quarters · filed 2021-08-10 | |||
| 2020-03-31 | -$2.05M 10-Q · filed 2021-05-12 | -$730.00K derived: sum of 2 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.38M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $2.06M 10-Q · filed 2020-11-13 | |||||
| 2018-12-31 | $928.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |